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Abstract We have cloned a human cDNA, DELGEF (deafness
locus associated putative guanine nucleotide exchange factor),
derived from a 225 kb genomic sequence of chromosome 11p14,
critical for the Usher 1C syndrome and for DFNB18, a locus for
non-syndromic sensorineural deafness. The amino acid sequence
of the protein hDelGEF1 is homologous to the nucleotide
exchange factor RCC1 for the small GTPase Ran. hDelGEF2
is derived from the same DELGEF gene by alternative splicing.
In addition, we have identified a murine homologue, mDelGEF.
The ubiquitously expressed soluble protein hDelGEF1 is found
both in the cytoplasm and in the nucleus. Overexpressed
hDelGEF2 colocalizes with mitochondria.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
RCC1, the ‘regulator of chromosome condensation’ [1], is
the ¢rst member of a family of structurally related proteins so
far identi¢ed [2]. It is the guanine nucleotide exchange factor
for the small Ras-related GTPase Ran [3], which in the GTP-
bound form is required for the dissociation of protein com-
plexes imported into the nucleus and for the formation of
similar complexes to be exported into the cytoplasm [4,5].
The three-dimensional structure of RCC1 resembles that of
a propeller with seven blades, formed from seven internal
repeats in the sequence. They are characterized by invariant
glycines in positions where no side chains are sterically per-
mitted [6].
Several genes encoding RCC1-related proteins have been
characterized as candidates for genetic disorders. Mutations
in the RPGR gene are discussed to be involved in the develop-
ment of the most common form of X-linked retinitis pigmen-
tosa. The predicted 90 kDa protein Rpgr is ubiquitously ex-
pressed and displays an RCC1-related repeat structure in its
N-terminal region [7,8]. Various mutations in this repeat
structure have been found in di¡erent patients [9,10]. An un-
usually large human protein of 532 kDa, p532, which weakly
stimulates guanine nucleotide exchange on the small GTPases
ARF1, Rab3A and Rab5, contains two regions of seven in-
ternal repeats each, distinctly related to RCC1 [11]. HERC2 is
a gene in the region involved in the Prader-Willi/Angelman
syndrome. It encodes a large protein thought to be implicated
in protein tra⁄cking, which comprises three RCC1-related
domains. It is de¢cient in mice with neuromuscular and sper-
miogenic abnormalities [12]. The CHC1L gene in chromo-
some region 13q14.3 encodes a ubiquitously expressed
mRNA for a protein of 551 amino acid residues, termed
Rlg. Its amino-terminal half also shows strong homology to
the seven tandem repeat structure of RCC1 [13].
Here we characterize a gene encoding a novel human ho-
mologue of RCC1, DelGEF, and show that it is located close
to the DFNB18 and USHER1C regions. Usher syndrome is
an autosomal recessive, genetically heterogeneous disorder
causing severe congenital deafness and retinitis pigmentosa.
In Usher 1 patients, vestibular dysfunction is also observed
[14]. To date, ¢ve candidate loci for this syndrome (USH1A^
E) have been analyzed, of which USH1C maps to 11p13^15
[15]. In addition, a locus for recessive non-syndromic sensori-
neural deafness (DFNB18) has been mapped to this region
[16].
2. Materials and methods
2.1. Isolation of a human cDNA clone from a fetal brain library,
sequencing, and Northern blot analysis
Databases were searched with the RCC1 and RPGR sequences to
identify homologous genes, using tblastx and blastn from the HUSAR
program package of the German Cancer Research Center. Sequencing
reactions were carried out with the Applied Biosystems automated
sequencer 373 A and dye terminator chemistry (Perkin Elmer). Using
the clone as template for PCR reaction with the forward primer
(5P-GGCTGTCCCATCCAACAG) and the reverse primer (5P-GC-
TTCAGTGCCATCTCCG), a PCR fragment of 645 bp was obtained.
30 ng of this fragment was labeled using the NonaPrimer Kit II
(Appligene/Oncor, Heidelberg, Germany). High density ¢lters with
cDNA from a human fetal brain library (DKFZp564, German Cancer
Research Center, Heidelberg, Germany) and from a human testis
library (DKFZp565, German Cancer Research Center, Heidelberg,
Germany) were pre-hybridized in 0.5 M sodium phosphate, pH 7.2,
7% SDS, 1 mM EDTA and 0.1 mg/ml salmon sperm DNA [17] at
65‡C for 1 h. Hybridization was performed for 14 h at 65‡C in the
same bu¡er containing the labeled probe at a concentration of
1.5U106 cpm/ml. The ¢lters were washed twice at 65‡C in a bu¡er
containing 0.2USSC and 0.2% SDS and exposed for 20 h to a Kodak
X-OMAT AR X-ray ¢lm. Human multiple tissue Northern blots
(Clontech) were hybridized under the same conditions as described
above. To con¢rm comparable loading of mRNA in each lane the
blots were hybridized with labeled human L-actin cDNA.
2.2. Chromosomal mapping of the terminal exon of DELGEF
Chromosomal DNA from mapping panel #2 (Coriell Institute for
Medical Research, Camden, NJ, USA) was used as template for PCR
reactions under the following conditions: 40 ng of genomic DNA,
1UPCR bu¡er, 200 WM dNTPs, 1.6 U TaKaRa Ex Taq (Boehringer
Ingelheim, Germany) in a total volume of 50 Wl. The forward primer
was 5P-CATGGCCCAGGAACCCTTTGTTTTGCT-3P, the reverse
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primer 5P-GTGACAGTAGGGAAGGGCCGAGGAGGAA-3P. After
an initial denaturation (94‡C for 1.5 min), 35 cycles of ampli¢cation
(94‡C for 30 s, 2.5 min 72‡C) were carried out, followed by a ¢nal
extension for 7 min at 72‡C (PTC-200 thermocycler, MJ Research).
2.3. Antibodies
The antiserum to the C-terminal sequence of DelGEF1 was raised
against the synthetic peptide CTSTQSQSDWSRNGGL (Fig. 2) and
the antiserum to the N-terminal region was raised against the N-ter-
minal peptide MEREPSASEAAPAAAC present in both proteins.
The cysteine residues were introduced for coupling each of these pep-
tides to keyhole limpet hemocyanin (Imject Maleimide Activated Car-
rier Protein #77105, Pierce, Rockford, IL, USA). Immunization of
rabbits was performed according to standard procedures (Eurogentec,
Seraing, Belgium). For antibody puri¢cation, the synthetic peptides
were coupled to UltraLink Iodoacetyl (#53155, Pierce, Rockford, IL,
USA). For immunoblotting 30 Wg of cell lysate or 15 ng of recombi-
nant hDelGEF protein was run on SDS gel electrophoresis and trans-
ferred to nitrocellulose membranes. The hDelGEF protein was de-
tected using a⁄nity-puri¢ed rabbit antibody to the C-terminus of
hDelGEF1.
2.4. Preparation of subcellular protein fractions
Packed HeLa cells (25 ml) were thawed in 100 ml of lysis bu¡er (20
mM Tris pH 7.5, 1 mM MgCl2 and protease inhibitor cocktail (Roche
Diagnostics, Mannheim, Germany)), and swollen on ice for 30 min.
They were lysed by 10 strokes with an S-type Dounce homogenizer
and centrifuged at 100 000Ug for 90 min. Supernatant and pellet were
separated for further analysis.
2.5. Expression cloning, protein production and puri¢cation
For bacterial expression, hDELGEF1 cDNA (DKFZp564O2248)
was used for PCR ampli¢cation with forward primer 5P-TTTCA-
TATGGAGCGCGAGCCCAGCGCCT-3P and 5P-TTTGTCGACT-
CACAGTCCCCCATTTCTGGAC-3P as the reverse primer. The
PCR product was ligated between the NdeI and XhoI sites in a
pET-14b vector (Novagen). For the expression of the recombinant
protein in Escherichia coli BL21(DE3), a 1.2 l culture was grown at
16‡C. Expression of the recombinant protein was induced with 0.5
mM isopropyl-L-D-thiogalactopyranoside (IPTG) for 3.5 h. Cells
were lysed in 20 mM HEPES (pH 7.6), 2 mM DTT, 1 mg lyso-
zyme/ml and EDTA-free protease inhibitor cocktail (Roche Diagnos-
tics, Mannheim, Germany). The lysate was sonicated ¢ve times, ad-
justed with 1 M NaCl to a ¢nal concentration of 100 mM NaCl and
centrifuged for 1 h at 100 000Ug. The supernatant was incubated for
2 h with 0.5 ml of a Ni-NTA agarose suspension. It was washed four
times with 20 mM HEPES (pH 7.6), 100 mM NaCl and 20 mM
imidazole. Elution was performed with 20 mM HEPES (pH 7.6),
100 mM NaCl and 1 M imidazole.
For expression in mammalian cells, DELGEF1 and DELGEF2 (Fig.
4) were cloned into a modi¢ed pCDNA3 vector, which contained an
in-frame £ag coding sequence downstream of the EcoRV site in the
multiple cloning region. For DELGEF1 and DELGEF2 cloning, the
forward primer 5P-GGAAGACTAAGCTATGGAGCGCGAGCC-
CAGCGCCT-3P was used, while the reverse primer 5P-CAGTCCCC-
CATTTCTGGACCA-3P was generated for DELGEF1 and primer 5P-
TGCTCTGAGCCACAAGAGACCTGTCTGA-3P for DELGEF2.
Both PCR products were digested with the restriction enzyme BpiI
and ligated to the modi¢ed pCDNA3 vector between the HindIII and
EcoRV restriction sites.
2.6. Immuno£uorescence studies
COS-7 cells on coverslips were transfected with plasmid DNA of
DELGEF1 and DELGEF2 by SuperFect transfection reagent (Qiagen,
Hilden, Germany). Sixty hours after transfection cells were ¢xed in
3% formaldehyde in phosphate bu¡ered saline (PBS) for 10 min and
washed twice with PBS. Cells were permeabilized for 5 min in 1%
Triton X-100 in PBS and washed twice with PBS. The antibodies to
the N- and C-terminal regions of hDelGEF1 were diluted 1:100 in 1%
bovine serum albumin in PBS. Cells were incubated at 25‡C for 1 h
with the antibodies and washed twice with PBS. FITC-coupled goat
anti-rabbit antibody (Dianova, Hamburg, Germany) diluted 1:200
was used as secondary antibody. For mitochondrial staining, ‘Mito-
tracker Red CMXRos’ (Molecular Probes, Leiden, The Netherlands)
was used according to the manufacturer.
3. Results
3.1. Northern blot analysis and elucidation of cDNA and amino
acid sequences of human and murine DelGEF
A human expressed sequence tag (EST) Image I.M.A.G.E.
Consortium clone ID 291525 (GB N67793) [18] distinctly ho-
mologous to human RCC1 and RPGR was identi¢ed by data-
base searching. This clone was obtained from Research Ge-
netics and sequenced. The sequence of 1243 bp did not fully
match the mRNA size of 1400 bp as determined by Northern
blot analysis (Fig. 1), which resulted in one major band of
some 1400 bp in all human adult tissues tested. Only in testis
a smaller variant of 1 kb was evident. The expression level
was high in brain, skeletal muscle, prostate and ovary, while it
was low in placenta, lung, and liver. In addition, DELGEF
was expressed in retina, since a partial clone, GB W25773,
was derived from a human retina library.
To obtain the full-length cDNA, high density ¢lters of a
human fetal brain library and a testis library were screened.
On the fetal brain library ¢lter one positive clone
(DKFZp564O2248) was identi¢ed. The sequence of this clone
showed a potential start ATG, but no in-frame stop codon in
the 5P untranslated region (Fig. 2A). The cDNA clone has a
total length of 1431 bp and encodes a protein of 458 amino
acid residues (48 987 Da). The 3P untranslated region contains
a polyadenylation signal (AATAAA), 15 nucleotides upstream
of the poly(A) tail.
Further database searches revealed a murine homologue,
I.M.A.G.E. Consortium clone ID 698116 (GB AA239362),
which was obtained from Research Genetics and sequenced.
This clone has a total length of 1430 bp and represents the
full-length cDNA (Fig. 2B). The ORF starts at position 19
and ends with the termination signal TAA at nucleotide 1411,
encoding a protein of 464 amino acid residues (49 194 Da).
The deduced human and murine amino acid sequences have
80% identity and are distinctly homologous (some 25%, Fig.
Fig. 1. Ubiquitous expression of hDELGEF mRNA. Top: Northern
blot analysis of the expression. The bars on both sides indicate
RNA size markers. Bottom: Reprobing of the same blot with L-ac-
tin to ensure loading of comparable amounts of mRNA.
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3) to RCC1, and to regions in Rpgr, HERC2, p532, and Rlg.
All these proteins share the repeat structure found in RCC1.
The individual putative propeller blades in DelGEF vary from
49 to 67 residues, blade six having an insert of 16 residues
(303^318) compared to the other proteins of this family. Sec-
ondary structure predictions indicate a £exible conformation
for this sequence.
3.2. Structure of the human DELGEF gene and localization on
chromosome 11p14
A database search revealed the hDELGEF gene to be part
of the sequenced PAC clones 6-130a9 (GB AC005728),
pDJ59m18 (GB AC004582) and 1082L12 (GB AC004736)
[19], which have been localized to chromosome 11p14 [20].
A comparison of the sequences of these clones with the
hDELGEF cDNA showed that the DELGEF gene comprises
11 exons. Exons 1^9 are present in PAC clone 6-130a9, exons
10 and 11 are found in clone pDJ59m18 (GB AC004582) (Fig.
4). The Whitehead chromosome marker D11S1310 corre-
sponds to a sequence in intron 9, and D11S1888 is only 32
kb downstream of the 3P-terminal exon 11, which is also part
of a third PAC clone 1082L12 (GB AC004736). 5P and 3P
Fig. 2. cDNA and predicted amino acid sequences of (A) human DelGEF1 (accession number AJ243950) and (B) the murine homologue mDel-
GEF (accession number AJ243952). The polyadenylation signal is underlined.
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splice sites of the exon-intron boundaries match the consensus
sequence patterns (Table 1). The exon sizes vary from 37 bp
(exon 10) to 366 bp (exon 11), and the intron sizes from 1.2
kb (intron 2) to 89.8 kb (intron 10). To con¢rm the published
mapping result we constructed a forward and reverse primer
surrounding the terminal exon of the hDELGEF gene and
used chromosomal DNA from a hybrid panel as template
for PCR. It resulted in the expected PCR fragment of 998
bp (according to GB ACC004582) only for chromosome 11
and for total human DNA, not for murine and hamster DNA
(not shown).
3.3. Alternatively spliced transcripts
Comparison of the sequences in Fig. 2A (DELGEF1) and
the Image I.M.A.G.E. Consortium clone ID 291525 (GB
N67793, DELGEF2) indicated alternative splicing. DELGEF2
lacks exon 9 (863^1029) (Fig. 4). This alters the ORF in exon
10 to a total of only 288 amino acid residues and 30 546 Da
for the encoded protein. The two proteins are identical up to
residue 281 (Thr), which in DelGEF2 is followed by the C-
terminal heptapeptide sequence GLLWLRA. This results in
the deletion of two out of the seven repeats. Both variants are
represented by EST clones in the database: I.M.A.G.E. Con-
sortium clones ID 173819 (GB H23780) corresponds to DEL-
GEF1, whereas clones 665437 (GB AA195166) and 174457
(GB H21559) represent DELGEF2. The alternatively spliced
transcripts are not detectable as separate bands on Northern
blots, because they do not di¡er signi¢cantly in size (Fig. 1).
3.4. Expression of human DELGEF and subcellular localization
of the protein
We raised antisera in rabbits to synthetic peptides derived
from the N- and C-terminal sequences of hDelGEF1. On
immunoblots of cell lysates, the a⁄nity-puri¢ed antibodies
recognized DelGEF1 as a soluble protein of 50 kDa (HeLa
supernatant, Fig. 5). Recombinant DelGEF1 migrates slightly
more slowly because of its His tag. The smaller DelGEF2 is
not detected by the antiserum to the C-terminal region of
DelGEF1, since it lacks the corresponding epitope. The anti-
serum to the N-terminal region, which is identical in both
proteins, did not detect either form in whole cell lysates, but
only DelGEF1 enriched by ion exchange chromatography
(not shown). An unidenti¢ed additional band of approxi-
mately 200 kDa was stained in HeLa cell lysates. Preincuba-
tion of the antiserum with the corresponding synthetic peptide
abolished this staining as well as that of DelGEF1 (not
shown). This might indicate cross-reaction with a similar
structure. However, on Northern blots with multiple tissues
(Fig. 1) no mRNA hybridized with our probe that corre-
sponded in size to such a large protein. We therefore believe
Fig. 3. Sequence identity between human and murine DelGEF and members of the RCC1-related protein family. The aligned sequences are
hDelGEF1 (this work), mDelGEF (this work), Rpgr [7,8], RCC1 [2]. HERC2 [12], p532 [11], and Rlg [13]. There are three RCC1 homology re-
gions in HERC2 and two in p532. Gaps are inserted to achieve maximum similarity. Positions in which 80% of the sequences have an identical
residue are highlighted in black, positions with at least 50% identical residues are shaded in gray. The conserved glycines are characteristic of
the structural repeats in this protein family. The three-dimensional structure of RCC1 resembles a propeller with seven blades [6]. Each of these
blades is indicated by an arrow. The C-terminal region 1A and the N-terminal region 1B jointly form one blade. Positions marked by an aster-
isk are referred to in the discussion section.
6
Fig. 4. Structure of the human DELGEF gene. The transcript DELGEF1 is represented by the sequence in Fig. 1 (top) and the I.M.A.G.E.
Consortium clone ID 173819 (GB H23780). The structure of the gene is derived from the sequences of the overlapping PAC clones 6-130a9
(GB AC005728), pDJ59m18 (GB AC004582) and 1082L12 (GB AC004736). The transcript DELGEF2 was found in the I.M.A.G.E. Consorti-
um clones IDs 291525, 665437 and 174457 (partial sequences GB N67793, AA195166 and H21559).
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that the 200 kDa protein on protein blots is not closely related
to DelGEF.
In immuno£uorescence studies, none of the sera stained
untransfected cells. However, when COS cells were transfected
with vectors carrying a variety of DelGEF constructs, the
overexpressed proteins were readily detected. Overexpression
of DELGEF1 results in nuclear plus cytoplasmic staining (Fig.
6B), whereas DelGEF2 appears to be associated with mito-
chondria (Fig. 6D). The same two patterns were seen when
£ag-tagged DelGEF was stained with anti-£ag antibodies (not
shown).
4. Discussion
We have identi¢ed a human cDNA, hDELGEF1, and its
murine homologue, mDELGEF, encoding proteins of 458 and
464 amino acid residues. In contrast to its small transcript, the
human DELGEF gene spans 225 kb in chromosome region
11p14. Defects in this region are considered to be responsible
for the USH1C syndrome and for the recessive non-syndromic
sensorineural deafness DFNB18. Genetic linkage analysis in
the French-Acadian population of Louisiana mapped the
USH1C gene between markers D11S902 and D11S1310 [21],
the latter marker being located in intron 9 of DELGEF. Re-
cently, the disease locus was thought to be more distal be-
tween the £anking markers D11S902 and D11S1890 [20,22].
The locus for a recessive non-syndromic sensorineural deaf-
ness, DFNB18, has also been mapped to this region [16], with
a maximum lod score of 4.4 for the microsatellite marker
D11S1888, 32 kb from the 3P end of DELGEF. Thus, muta-
tions in DELGEF may be involved in both types of deafness.
DelGEF belongs to the RCC1-related family of proteins,
which shares a structure of seven sequence repeats of 40^70
residues each, characterized by highly conserved glycines (Fig.
3). RCC1 is the nucleotide exchange factor for the small nu-
clear GTPase Ran which regulates nucleocytoplasmic trans-
port. Its three-dimensional structure resembles a propeller
with seven blades. The conserved glycines mark positions
where no side chain is permitted because of sterical restraints.
A WG motif in each blade except in blade two is involved in
forming the hydrophobic core, and most of the blades display
a conserved (cis)Pro. Five histidine residues in RCC1 are con-
served, in positions 78 (corresponding to His-60 in human and
murine DelGEF), 130, 183 (His-163 in DelGEF), 305 and 410.
These residues occupy analogous positions in individual
blades of the propeller and are believed to stabilize the struc-
ture. hDelGEF1 carries the characteristic GXXH sequence in
the N-terminal part of all blades except blade three. Muta-
tions in H78 or in H304 of RCC1 resulted in a markedly
reduced nucleotide exchange activity [23,24].
Conservation of the blade structure is essential. For exam-
ple, loss of function in another family member, Rpgr, in-
volved in X-linked retinitis pigmentosa, is believed to result
from mutations in conserved residues. In patients, conserved
glycines (codons 60 and 215, corresponding to 41 and 197 in
RCC1 and to 21 and 178 in DelGEF) in the RCC1-related
region were found to be mutated to valine, and a conserved
histidine (codon 98, corresponding to H78 in RCC1 and to
H60 in DelGEF) was substituted by a glutamine [7,9,10]. In
other patients, nonsense mutations resulted in a premature
stop codon within the RCC1 homology region [7].
Speci¢c structural elements for individual functions appear
to be superimposed on the propeller sca¡old, e.g. an extra L-
sheet protruding from blade three in RCC1 is thought to be
responsible for its Ran-speci¢c guanine nucleotide exchange
factor activity [3]. In human and murine DelGEF, the unique
Table 1
Exon-intron junctions of human DELGEF
Exon Size (bp) cDNA position Donor sites Intron Size (kb) Acceptor sites
1 78 1^78 CTGGgtacgt 1 4.9 ccctagGGTG
2 136 79^214 ACAGgtaatt 2 1.2 ttgcagATGG
3 156 215^370 ACAGgtgagt 3 2.1 ttgcagAAAA
4 95 371^465 TGAGgtgagg 4 3.9 tgacagCTCC
5 61 466^526 ACAGgtgatc 5 4.6 gggaagCGAG
6 114 527^640 ACAGgtaaga 6 2.8 ttgtagGTCT
7 63 641^703 ACAGgtaggt 7 4.3 tttaagATGC
8 159 704^862 ACAGgtgaga 8 29.0 ttttagAAAC
9 167 863^1029 TGAGgtagga 9 80.8 ttacagGTCT
10 37 1030^1066 ATTGgtaagt 10 89.8 tcacagGTGG
11 366 1067^1432
Fig. 5. Immunodetection of hDelGEF1 protein in cell lysates. 15 ng
of recombinant His-tagged hDelGEF protein expressed in E. coli
and 30 Wg of HeLa total lysate, HeLa 100 000Ug pellet and
100 000Ug supernatant were run on a SDS-PAGE gel and blotted
onto nitrocellulose. For immunodetection a⁄nity-puri¢ed antibodies
to the C-terminus of hDelGEF1 were used.
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insert in blade six (residues 303^318) may be functionally
important.
The amount of DelGEF protein in cells is low. DelGEF1
can be detected in immunoblots of cell lysates (Fig. 5), but in
immuno£uorescence studies it is seen only upon overexpres-
sion in transfected cells (Fig. 6B). The existence of DELGEF2
is indicated at the cDNA level, but has not been demonstrated
by immunostaining of protein bands on blots of cell lysates.
Notably, the last two of the seven putative propeller blades
are deleted from this smaller protein. A similar situation was
observed with murine Rpgr, where the last two repeats of the
RCC1 homology region are deleted in one splice variant [25].
The truncation of DelGEF results in an altered location of
overexpressed DelGEF2 at the mitochondria (Fig. 6D).
The closest homologue to DelGEF in Saccharomyces cere-
visiae is the alpha tubulin suppressor ATS1p [26], which also
lacks the C-terminal two blades. This protein appears to in-
£uence microtubule stability, since overexpression of the non-
essential ATS1 gene rescues both the growth and microtubule
phenotypes of a speci¢c class of K-tubulin mutations, class 2
tub1, that cause growth arrest with excess microtubules [27].
Overexpression of the yeast RCC1 homologue SRM1/PRP20
also suppresses class 2 mutants. Similarly, the readily soluble
DelGEF proteins could modulate mammalian microtubules,
perhaps by interaction with a microtubule-associated protein.
Yet as with ATS1 in yeast, no visible e¡ect on the number
and structure of normal microtubules in COS-7 cells was ob-
served upon overexpression of hDELGEF1 or 2 (not shown).
Mutation analysis of the DELGEF gene or of cDNA from
well characterized patients su¡ering from USH 1C or
DFNB18 deafness and knockout of the murine DELGEF
gene may help to clarify its role.
Acknowledgements: We are grateful to Andreas Hunziker for analyz-
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